Bernstein raises Cigna Group price target to $381
Bernstein analyst Lance Wilkes maintained an Outperform rating on Cigna Group and raised the price target to $381 from $371, signaling a positive outlook.
*this image is generated using AI for illustrative purposes only.
Bernstein analyst Lance Wilkes has maintained an Outperform rating on Cigna Group, raising the price target to $381 from $371. The revised target indicates an increased valuation outlook for the healthcare company's stock.
The rating affirmation and price target adjustment were detailed in a recent research note. Cigna Group trades on the NYSE under the ticker CI.
What specific factors drove Bernstein to raise Cigna's price target?
How might Cigna's recent performance influence its competitive position in the healthcare sector?
What are the potential risks that could prevent Cigna from reaching the new price target?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
